Novo Nordisk Clinical Trial Call Center

Phoenix, Arizona 85018

0 studies enrolling now · 2 studies all time

What they study most

Acquired Bleeding Disorder, Diabetes, Diabetes Mellitus, Type 2, Trauma

Studies at this site

• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™) — Completed
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma — Withdrawn before enrolling